INTEGRA LIFESCIENCES HOLDINGS CORP Business Acquisition, Pro Forma Net Income (Loss)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Business Acquisition, Pro Forma Net Income (Loss) of $81.73 million for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2020-02-21
- INTEGRA LIFESCIENCES HOLDINGS CORP business acquisition, pro forma net income (loss) for the quarter ending 2017-12-31 was $57.67M.
- INTEGRA LIFESCIENCES HOLDINGS CORP business acquisition, pro forma net income (loss) for the quarter ending 2017-09-30 was $1.39M, a 92.44% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP business acquisition, pro forma net income (loss) for the quarter ending 2017-06-30 was $14.27M, a 12.10% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP business acquisition, pro forma net income (loss) for the quarter ending 2017-03-31 was $8.62M, a 101.61% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP business acquisition, pro forma net income (loss) for fiscal 2017 was $81.73M, a 196.98% increase from fiscal 2016.
- INTEGRA LIFESCIENCES HOLDINGS CORP business acquisition, pro forma net income (loss) for fiscal 2016 was $27.52M, a 157.34% increase from fiscal 2015.
- INTEGRA LIFESCIENCES HOLDINGS CORP business acquisition, pro forma net income (loss) for fiscal 2015 was $10.69M, a 73.74% decline from fiscal 2014.
- INTEGRA LIFESCIENCES HOLDINGS CORP business acquisition, pro forma net income (loss) for fiscal 2014 was $40.72M, a 13.76% increase from fiscal 2013.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 3 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 12 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $57.67M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $59.05M derived: sum of 2 quarters · filed 2020-02-21 | $73.33M derived: sum of 3 quarters · filed 2020-02-21 | $81.73M 10-K · filed 2020-02-21 | ||||
| 2017-09-30 | $1.39M 10-Q · filed 2018-11-01 | $15.66M derived: sum of 2 quarters · filed 2018-11-01 | $24.06M 10-Q · filed 2018-11-01 | $24.09M 10-Q · filed 2017-10-26 | $19.62M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $14.27M 10-Q · filed 2018-07-26 | $22.85M 10-Q · filed 2018-07-26 | $19.88M 10-Q · filed 2017-07-26 | $18.23M derived: sum of 3 quarters · filed 2019-02-26 | $36.55M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $8.62M 10-Q · filed 2018-04-26 | $7.82M 10-Q · filed 2017-04-26 | $3.96M derived: sum of 2 quarters · filed 2019-02-26 | $22.28M derived: sum of 3 quarters · filed 2019-02-26 | $35.01M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | -$4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $13.66M derived: sum of 2 quarters · filed 2019-02-26 | $26.39M derived: sum of 3 quarters · filed 2019-02-26 | $27.52M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $18.32M 10-Q · filed 2017-10-26 | $31.05M derived: sum of 2 quarters · filed 2017-10-26 | $32.18M 10-Q · filed 2017-10-26 | $60.51M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $12.73M 10-Q · filed 2017-07-26 | $15.22M 10-Q · filed 2017-07-26 | $42.20M derived: sum of 3 quarters · filed 2018-03-01 | $11.49M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $4.28M 10-Q · filed 2017-04-26 | $29.46M derived: sum of 2 quarters · filed 2018-03-01 | -$1.24M derived: sum of 3 quarters · filed 2018-03-01 | $12.34M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $25.19M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$5.52M derived: sum of 2 quarters · filed 2018-03-01 | $8.07M derived: sum of 3 quarters · filed 2018-03-01 | $10.69M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | -$30.71M 10-Q · filed 2016-10-28 | -$31.70M 10-Q · filed 2015-11-04 | -$17.12M derived: sum of 2 quarters · filed 2016-10-28 | -$14.49M 10-Q · filed 2016-10-28 | -$5.93M 10-Q · filed 2015-11-04 | $16.66M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-06-30 | $13.59M 10-Q · filed 2016-07-28 | $26.89M 10-Q · filed 2016-07-28 | $7.01M 10-Q · filed 2015-07-31 | $47.36M derived: sum of 3 quarters · filed 2017-02-23 | $57.52M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-03-31 | $13.31M 10-Q · filed 2016-04-27 | $5.57M 10-Q · filed 2015-05-01 | $33.78M derived: sum of 2 quarters · filed 2017-02-23 | $43.94M derived: sum of 3 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $20.47M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $30.63M derived: sum of 2 quarters · filed 2017-02-23 | $40.72M 10-K · filed 2017-02-23 | $43.81M 10-K · filed 2015-02-27 | ||||
| 2014-09-30 | $10.16M 10-Q · filed 2015-11-04 | $20.25M 10-Q · filed 2015-11-04 | ||||||
| 2014-06-30 | $12.58M 10-Q · filed 2015-07-31 | |||||||
| 2013-12-31 | $35.80M 10-K · filed 2016-02-26 | -$7.30M 10-K · filed 2015-02-27 | ||||||
| 2011-12-31 | $5.55M derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $14.96M derived: sum of 2 quarters · filed 2014-06-20 | $13.64M derived: sum of 3 quarters · filed 2014-06-20 | $23.24M 8-K · filed 2014-06-20 | ||||
| 2011-09-30 | $9.42M 10-Q · filed 2012-10-24 | $9.92M 10-Q · filed 2011-10-31 | $8.09M derived: sum of 2 quarters · filed 2012-10-24 | $17.69M 10-Q · filed 2012-10-24 | $17.95M 10-Q · filed 2011-10-31 | $32.64M derived: sum of 4 quarters · filed 2012-10-24 | ||
| 2011-06-30 | -$1.33M 10-Q · filed 2012-07-31 | $8.28M 10-Q · filed 2012-07-31 | $23.23M derived: sum of 3 quarters · filed 2012-07-31 | $36.65M derived: sum of 4 quarters · filed 2012-07-31 | ||||
| 2011-03-31 | $9.60M 10-Q · filed 2012-04-26 | $24.55M derived: sum of 2 quarters · filed 2012-04-26 | $37.97M derived: sum of 3 quarters · filed 2012-04-26 | |||||
| 2010-12-31 | $14.95M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $28.37M derived: sum of 2 quarters · filed 2012-02-27 | $51.82M 10-K · filed 2012-02-27 | |||||
| 2010-09-30 | $13.42M 10-Q · filed 2011-10-31 | $36.87M 10-Q · filed 2011-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |